4/A//SEC Filing
Mika Yuval 4/A
Accession 0001213900-23-037019
CIK 0001814114other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 8:13 PM ET
Size
7.0 KB
Accession
0001213900-23-037019
Insider Transaction Report
Form 4/AAmended
Mika Yuval
See Remarks
Transactions
- Award
Right to Receive Earnout Shares
2023-01-26+17,704→ 17,704 total→ Common Stock (17,704 underlying)
Footnotes (2)
- [F1]On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently omitted the right to receive Earnout Shares (defined below). In accordance with Instruction 9(a) to Form 4, this amendment is filed to add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment. The original Form 4 also mistakenly indicated that the Reporting Person is a director of the Issuer; the Reporting Person is not a director of the Issuer.
- [F2]Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001949285
Filing Metadata
- Form type
- 4/A
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 8:13 PM ET
- Size
- 7.0 KB